CPT code 96416 denotes the initiation of intravenous chemotherapy delivered via a portable or implantable pump. This code captures the clinical act of starting continuous or ambulatory pump-based chemotherapy and is relevant for accurate billing of oncology infusion services across settings that use pump devices. Nationally, the code matters for proper reimbursement of infusion start procedures and for consistent documentation of pump-based oncology care.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of where 96416 is used clinically, how it fits into chemotherapy service lines, and the common coding considerations that affect payment and claims processing. The publication outlines expected sites of service, typical clinical workflows around pump initiation, and the relationship of this code to broader oncology infusion billing practices.

The content provides benchmarks and policy context relevant to payers listed above, highlights clinical contexts for pump-based chemotherapy initiation, and summarizes common modifiers and administrative details associated with claims using CPT code 96416. Data not available in the input is noted where applicable.